291 related articles for article (PubMed ID: 950656)
1. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
[TBL] [Abstract][Full Text] [Related]
2. 2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific and potent antidiuretic agonists.
Lammek B; Bankowski K; Misicka A; Manning M; Seto J; Sawyer WH
J Med Chem; 1989 Jan; 32(1):244-7. PubMed ID: 2909737
[TBL] [Abstract][Full Text] [Related]
3. Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
Gunnar E; Lindeberg G; Melin P; Larsson LE
Int J Pept Protein Res; 1976; 8(2):193-8. PubMed ID: 1270191
[TBL] [Abstract][Full Text] [Related]
4. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
Lowbridge J; Manning M; Haldar J; Sawyer W
J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
[TBL] [Abstract][Full Text] [Related]
5. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
Bankowski K; Manning M; Haldar J; Sawyer WH
J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
[TBL] [Abstract][Full Text] [Related]
7. [1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
Manning M; Lowbridge J; Stier CT; Haldar J; Sawyer WH
J Med Chem; 1977 Sep; 20(9):1228-30. PubMed ID: 926126
[TBL] [Abstract][Full Text] [Related]
8. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
Lempicka E; Slaninova J; Olma A; Lammek B
J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
[TBL] [Abstract][Full Text] [Related]
9. Potent antidiuretic agonists, deamino-vasopressin and desmopressin, and their inverso analogs: NMR structure and interactions with micellar and liposomic models of cell membrane.
Lubecka EA; Sikorska E; Sobolewski D; Prahl A; Slaninová J; Ciarkowski J
Biopolymers; 2016 May; 106(3):245-59. PubMed ID: 26916937
[TBL] [Abstract][Full Text] [Related]
10. Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.
Cort JH; Schück O; Stríbrná J; Skopková J; Jost K; Mulder JL
Kidney Int; 1975 Nov; 8(5):292-302. PubMed ID: 1195561
[TBL] [Abstract][Full Text] [Related]
11. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
Jones DA; Sawyer WH
J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
[TBL] [Abstract][Full Text] [Related]
12. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
[TBL] [Abstract][Full Text] [Related]
13. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
14. [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),4-valine,-8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin.
Lowbridge J; Manning M; Haldar J; Sawyer WH
J Med Chem; 1978 Mar; 21(3):313-5. PubMed ID: 628009
[TBL] [Abstract][Full Text] [Related]
15. Surprising pharmacological activity of analogues designed by substitution of position 3 in arginine vasopressin (AVP) and 8-D-arginine vasopressin with L-2-napthylalanine.
Lammek B; Konieczna E; Trzeciak HI; Kozłowski A; Szymkowiak J; Stojko R; Kupryszewski G
J Pharm Pharmacol; 1996 Mar; 48(3):316-9. PubMed ID: 8737061
[TBL] [Abstract][Full Text] [Related]
16. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
Buku A; Yamin N; Gazis D
Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
Lammek B; Derdowska I; Melin P
Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin analog with extraordinarily high antidiuretic potency: a study of conformation and activity.
Smith CW; Walter R
Science; 1978 Jan; 199(4326):297-9. PubMed ID: 619455
[TBL] [Abstract][Full Text] [Related]
19. Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues.
Vilhardt H; Bie P
Eur J Pharmacol; 1983 Sep; 93(3-4):201-4. PubMed ID: 6641789
[TBL] [Abstract][Full Text] [Related]
20. The effects of two analogues of arginine-vasopressin (ornithine-vasopressin and desamino-D-arginine-vasopressin) on kidney function in sheep.
Yesberg NE; Henderson M; Budtz-Olsen OE
Q J Exp Physiol Cogn Med Sci; 1978 Apr; 63(2):179-88. PubMed ID: 247535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
